哮喘联盟

   摘要
   目的：回顾塔斯马尼亚哮喘儿童的药物供给和家长报告的儿童哮喘管理情况，强调未来干预的证据-实践差距。
   方法：受试药房使用软件应用程序从配药记录中提取数据，帮助识别哮喘儿童。通过电子邮件发送哮喘管理的调查评估内容给确诊患儿的家长。分析配药和调研数据。
   结果：共纳入23家药店经软件识别的939名儿童。收集了353名家长的调查问卷。在过去一年里，短效β2受体激动剂供给量为56.1%，预防药物为76.5% (吸入糖皮质激素52.3%；白三烯受体拮抗剂31.3%；吸入色酮类0.6%)，长效β2受体激动剂(LABAs)为25.7%，口服糖皮质激素为21.5%。大约一半的儿童在接受吸入糖皮质激素治疗的同时使用了长效β2受体激动剂。在哮喘控制不充分的儿童中，高达38.2%的儿童制定一个哮喘行动计划，高达36.8%的儿童没有常规使用储雾罐，高达22.8%的儿童没有接受预防药物。
   结论：上述结果表明了儿童哮喘管理中的差距，尤其是高危人群预防药物供给不足，长效β2受体激动剂的高供给、以及储雾罐和哮喘行动计划使用的不足。这些地区应该给予有针对性的干预措施以改善儿童哮喘管理。
 

（刘国梁 审校）
J Paediatr Child Health. 2013 Jun 9. doi: 10.1111/jpc.12267. [Epub ahead of print]

 

Review of the management of childhood asthma in Tasmania.
 

Bereznicki BJ, Norton LC, Beggs SA, Gee P, Bereznicki LR.
 

Abstract
AIM: To review the supply of medications to children with asthma and parent-reported management of childhood asthma in Tasmania and highlight evidence-practice gaps for future interventions.
METHODS: Participating pharmacies ran a software application that extracted data from dispensing records and helped to identify children with asthma. Parents of identified children were mailed a survey evaluating components of asthma management. Dispensing and survey data were analysed.
RESULTS: A total of 939 children from 23 pharmacies were identified by the software and deemed eligible for inclusion. Surveys were received from 353 (37.6%) parents. In the past year, short-acting beta-2 agonists were supplied to 56.1% of the cohort, preventers to 76.5% (inhaled corticosteroids 52.3%;leukotriene receptor antagonists 31.3%; inhaled cromones 0.6%), long-acting beta-2 agonists (LABAs) to 25.7% and oral corticosteroids to 21.5%.Approximately half of the children receiving inhaled corticosteroids were concurrently receiving a LABA. Among children with indicators of inadequately controlled asthma, up to 73.7% of their parents reported that their asthma was adequately controlled, up to 38.2% did not possess an Asthma Action Plan, up to 36.8% were not regularly using a spacer and up to 22.8% had not received a preventer.
CONCLUSION: These results indicate gaps in childhood asthma management, in particular, undersupply of preventers in high-risk patient groups, high supply of LABAs and insufficient spacer and asthma action plan usage. These areas should be targeted for interventions to improve childhood asthma management.
 

J Paediatr Child Health. 2013 Jun 9. doi: 10.1111/jpc.12267. [Epub ahead of print]